Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123832192 | 12383219 | 2 | F | 2015 | 20160726 | 20160518 | 20160809 | PER | US-PFIZER INC-2016254322 | PFIZER | 67.00 | YR | F | Y | 78.47000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123832192 | 12383219 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | ONE PILL BY MOUTH EACH DAY | Y | 20235 | 1 | DF | |||||||
| 123832192 | 12383219 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | THREE TAKE TIMES A WEEK | Y | 20235 | /wk | |||||||||
| 123832192 | 12383219 | 3 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 7.5MG NO MORE THAT TWO TABLETS BY MOUTH A DAY WHEN NEEDED | 0 | ||||||||||
| 123832192 | 12383219 | 4 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 123832192 | 12383219 | 5 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | CAPSULE | QD | ||||||
| 123832192 | 12383219 | 6 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 123832192 | 12383219 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 123832192 | 12383219 | 8 | C | BAYER ASPIRIN | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | TABLET | |||||||
| 123832192 | 12383219 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000IV ONE GELCAPSULE DAILY | 0 | 1 | DF | ||||||||
| 123832192 | 12383219 | 10 | C | ONE A DAY VITACRAVES | 2 | Oral | TWO TABLET BY MOUTH DAILY | 0 | 2 | DF | TABLET | ||||||||
| 123832192 | 12383219 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | ||||||
| 123832192 | 12383219 | 12 | C | PROGESTERONE. | PROGESTERONE | 1 | Oral | 100 MG, 1X/DAY AT NIGHT | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123832192 | 12383219 | 1 | Pain in extremity |
| 123832192 | 12383219 | 3 | Back pain |
| 123832192 | 12383219 | 4 | Arthralgia |
| 123832192 | 12383219 | 5 | Depression |
| 123832192 | 12383219 | 6 | Blood cholesterol increased |
| 123832192 | 12383219 | 7 | Gastrooesophageal reflux disease |
| 123832192 | 12383219 | 9 | Supplementation therapy |
| 123832192 | 12383219 | 10 | Supplementation therapy |
| 123832192 | 12383219 | 11 | Glucose tolerance impaired |
| 123832192 | 12383219 | 12 | Hormone therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123832192 | 12383219 | Condition aggravated | |
| 123832192 | 12383219 | Feeling abnormal | |
| 123832192 | 12383219 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123832192 | 12383219 | 1 | 2015 | 2015 | 0 | |
| 123832192 | 12383219 | 5 | 2015 | 0 |